Skip to main content
Premium Trial:

Request an Annual Quote

NuGen, Advanced Liquid Logic Partner on NGS Sample Prep System

NEW YORK (GenomeWeb News) – NuGen Technologies and Advanced Liquid Logic today announced an exclusive co-development and supply agreement for commercialization of Advanced Liquid's instrumentation, software, and digital microfluidic cartridge technology.

The companies also are collaborating with the Broad Institute on method development on the digital microfluidic cartridge.

Advanced Liquid's benchtop system enables "direct electrical manipulation of sub-microliter droplets without requiring pumps, valves, or channels," the firms said in a statement. NuGen will market the system under the Mondrian SP brand name.

The initial commercialization target will be next-generation sequencing library preparation protocols, which are being co-developed with the Broad Institute, for Illumina sequencing platforms. The technology will also be developed for NuGen's Ovation RNA-Seq and Encore Amplification Free NGS Library Systems, and those products are expected to become available by the end of the year.

Financial and other terms of the deal were not disclosed.

NuGen CEO Elizabeth Hutt said her firm has provided researchers capabilities to work with very small amounts of starting materials, and "[i]ntroduction of this system is a natural extension of that mission, as the system allows for even smaller amounts of starting materials by working in volumes unachievable with any other existing technologies."

Based in San Carlos, Calif., NuGen develops sample preparation solutions for RNA and DNA. Advanced Liquid is based in Research Triangle Park, NC, and develops digital microfluidic technologies.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.